A phase IIb, randomised, double-blind, placebo controlled, dose finding study assessing the haemodynamic safety and 'at home' efficacy of inhaled VR004 [apomorphine] in patients with erectile dysfunction (ED)
Latest Information Update: 21 Jul 2016
At a glance
- Drugs Apomorphine (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Vectura
- 01 Sep 2006 New trial record.